MedPath

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Clotrimazole and Betamethasone Dipropionate

Approved
Approval ID

bbf26437-c9b4-d8e6-e053-2a95a90a0062

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 22, 2021

Manufacturers
FDA

Direct Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72189-182
Application NumberANDA202894
Product Classification
M
Marketing Category
C73584
G
Generic Name
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Product Specifications
Route of AdministrationTOPICAL
Effective DateFebruary 22, 2021
FDA Product Classification

INGREDIENTS (12)

CETEARETH-30Inactive
Code: 1R9DCZ5FOX
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
CETOSTEARYL ALCOHOLInactive
Code: 2DMT128M1S
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RN
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
CLOTRIMAZOLEActive
Quantity: 10 mg in 1 g
Code: G07GZ97H65
Classification: ACTIB
BETAMETHASONE DIPROPIONATEActive
Quantity: 0.5 mg in 1 g
Code: 826Y60901U
Classification: ACTIM
PHOSPHORIC ACIDInactive
Code: E4GA8884NN
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE - FDA Drug Approval Details